Insider Transactions in Q1 2024 at Merit Medical Systems Inc (MMSI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2024
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Bona fide gift
|
Direct |
1,180
-4.58%
|
-
|
|
Mar 12
2024
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
6,480
-17.8%
|
$479,520
$74.22 P/Share
|
|
Mar 07
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-37.19%
|
$1,875,000
$75.68 P/Share
|
|
Mar 07
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+27.11%
|
$700,000
$28.2 P/Share
|
|
Mar 06
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+33.6%
|
$330,000
$44.8 P/Share
|
|
Mar 06
2024
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Bona fide gift
|
Direct |
315
-3.08%
|
-
|
|
Mar 04
2024
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,630
-20.46%
|
$199,880
$76.51 P/Share
|
|
Mar 04
2024
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,338
+41.63%
|
-
|
|
Mar 04
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,630
-5.86%
|
$199,880
$76.51 P/Share
|
|
Mar 04
2024
|
Joseph Wright CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,429
+14.96%
|
-
|
|
Mar 04
2024
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,319
+50.0%
|
-
|
|
Mar 04
2024
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
4,567
-15.05%
|
$347,092
$76.51 P/Share
|
|
Mar 04
2024
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
14,429
+21.47%
|
-
|
|
Mar 04
2024
|
Fred P Lampropoulos PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,343
-0.78%
|
$634,068
$76.51 P/Share
|
|
Mar 04
2024
|
Fred P Lampropoulos PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,534
+2.0%
|
-
|
|
Mar 04
2024
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,630
-12.45%
|
$199,880
$76.51 P/Share
|
|
Mar 04
2024
|
Raul Parra Jr. CFO AND TREASURER |
BUY
Grant, award, or other acquisition
|
Direct |
14,429
+29.75%
|
-
|
|
Mar 04
2024
|
Thomas James Gunderson |
SELL
Open market or private sale
|
Direct |
18,157
-48.53%
|
$1,379,932
$76.03 P/Share
|
|
Mar 04
2024
|
Thomas James Gunderson |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+40.06%
|
$850,000
$34.4 P/Share
|
|
Mar 04
2024
|
Stephen C. Evans |
SELL
Open market or private sale
|
Direct |
1,000
-12.16%
|
$76,000
$76.35 P/Share
|
|
Jan 22
2024
|
F. Ann Millner |
SELL
Open market or private sale
|
Direct |
20,000
-40.03%
|
$1,600,000
$80.0 P/Share
|
|
Jan 22
2024
|
F. Ann Millner |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+28.59%
|
$680,000
$34.4 P/Share
|